Basic Information
UltraTechneKow FM Generator
SOLUTION
Regulatory Information
SIN14082P
January 19, 2012
Prescription Only
Therapeutic
INTRAVENOUS
August 10, 2023
June 4, 2025
XV09FX01
Company Information
QT INSTRUMENTS (S) PTE LTD
QT INSTRUMENTS (S) PTE LTD
Active Ingredients
Strength: 2.15, 4.3, 6.45, 8.6, 10.75, 12.9, 17.2, 21.5, 25.8, 30.1, 34.4, 43 (GBq)
Strength: 2.08,4.16,6.24,8.32,10.4,12.47,16.63,20.79,24.95,29.11,33.26,41.58 (Gbq)
Detailed Information
Contraindications
**4.3 Contraindications** Hypersensitivity to the active substance or any of the excipients.
Indication Information
**4.1 Therapeutic Indications** This medicinal product is for diagnostic use only. The eluate from the generator (Sodium Pertechnetate (99mTc) Injection Ph. Eur.) may be used as a reagent for labelling of various carrier compounds supplied as kits or administered directly in-vivo. 1. When administered intravenously, the sterile sodium pertechnetate (99mTc) solution is used as a diagnostic aid in the following: - **Thyroid scintigraphy:** direct imaging and measurement of thyroid uptake to give information on the size, position, nodularity and function of the gland in thyroid disease. - **Salivary gland scintigraphy:** to assess salivary gland function and duct patency. - **Location of ectopic gastric mucosa:** Meckel's diverticulum. - **Cerebral scintigraphy:** to identify breaches in the blood-brain barrier caused by tumour, infarction, haemorrhage and oedema, when no other methods are available. 2. When used in conjunction with pre-treatment with a reducing agent to effect technetium (99mTc)-labelling of red blood cells: - **Cardiac and vascular scintigraphy** - angiocardioscintigraphy for: ✽ evaluation of ventricular ejection fraction ✽ evaluation of global and regional cardiac wall motion ✽ myocardial phase imaging - organ perfusion or vascular abnormalities imaging - **Diagnosis and localisation of occult gastrointestinal bleeding.** 3. Following instillation of sterile sodium pertechnetate (99mTc) solution into the eye: - **Lacrimal duct scintigraphy:** to assess patency of tear ducts